The Independent Voice of
European Private Equity

Advanced Search

ArchiMed carves out in vitro diagnostics specialist Diesse

Talya Misiri 23 May 2019

ArchiMed has acquired Italian in vitro diagnostics specialist Diesse, its second cross border carve-out in less than three months.

The acquisition in Diesse Diagnostica Senese was made via the ArchiMed MED II fund.

Related Articles

VC performance hits new high

23/07/19

Waterland-backed Median makes two deals

23/07/19

LBO France makes investment in Ecritel

23/07/19

Agilitas-backed Hydro makes second bolt-on

23/07/19

Innova Capital buys Optiplaza

23/07/19

Maven invests in computing company ebb3

23/07/19